OTCMKTS:HDII Hypertension Diagnostics (HDII) Stock Price, News & Analysis → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free HDII Stock Alerts $0.0002 0.00 (0.00%) (As of 04/25/2024 ET) Add Compare Share Share Today's Range$0.0002▼$0.000250-Day Range N/A52-Week Range$0.0001▼$0.0045VolumeN/AAverage Volume4,409 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartFinancialsSEC FilingsStock AnalysisChartFinancialsSEC Filings Get Hypertension Diagnostics alerts: Email Address Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> About Hypertension Diagnostics Stock (OTCMKTS:HDII)Hypertension Diagnostics, Inc. designs, develops, manufactures, and markets proprietary noninvasive medical devices that detect subtle changes in the elasticity of arteries in the United States and internationally. It offers CVProfilor, which allows a physician to non-invasively assess the elasticity of small and large arteries, of which small artery elasticity is the earliest and sensitive marker of cardiovascular disease. The company offers CVProfilor DO-2020, which provides a patient's arterial elasticity indices used in the assessment for underlying vascular disease; CVProfilor MD-3000 that offers a sensitive and specific guide to the presence of blood vessel disease; and HD/PulseWave CR-2000 research cardiovascular profiling system, which provides researchers and scientists with a non-invasive means to assess arterial elasticity in support of human research in various areas. Its products collect 30 seconds of blood pressure waveform data, perform an analysis of the digitized blood pressure waveforms, and generate a CVProfile report that contains information on blood pressure, heart rate, pulse pressure, body surface area, body mass index, and C1-large and C2-small artery elasticity indices. The company sells its products to primary care physicians, cardiologists, health care professionals, trained medical personnel, research investigators at academic medical research centers, government institutes, cardiovascular specialists, and pharmaceutical firms. It markets its products through a representative organization in the United States. Hypertension Diagnostics, Inc. was founded in 1988 and is based in Richmond Hill, Canada.Read More HDII Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart HDII Stock News HeadlinesApril 11, 2024 | msn.comHypertensive disorders of pregnancy increase risk of cardiovascular death after giving birth, study findsFebruary 23, 2024 | msn.comUnderstanding the role played by HIV in pulmonary hypertensionApril 25, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.January 28, 2024 | msn.comWhat Is Pulmonary Hypertension?September 30, 2023 | msn.comFG laments rising deaths from hypertension, strokeSeptember 19, 2023 | msn.comAlmost half of adults with hypertension unaware they have it: WHOSeptember 9, 2023 | thestreet.comHypertension Diagnostics, Inc.August 20, 2023 | benzinga.comPulmonary Arterial Hypertension (PAH) Market to Hit US$ 12.7 Billion by 2033: Fact.MR ReportApril 25, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.July 25, 2023 | yahoo.comWhat Causes High Blood Pressure (HBP)?May 26, 2023 | finance.yahoo.comHDII - Hypertension Diagnostics, Inc.March 8, 2023 | forbes.comHow To Lower High Blood Pressure SafelyFebruary 24, 2023 | omaha.comFootballers' Concussion Symptom Burden Linked to HypertensionFebruary 7, 2023 | marketwatch.comPulmonary Arterial Hypertension (Pah) Medicine Market Latest Trends, Industry Size and Future Prospects 2029February 1, 2023 | msn.comEverything you need to know about paediatric hypertension as a parentJanuary 16, 2023 | msn.comHypertension Diet: 5 Essential Foods to Manage High Blood Pressure NaturallyDecember 23, 2022 | marketwatch.comChronic Thromboembolic Pulmonary Hypertension Market Size, Share and Forecast 2028 with Top Countries DataSeptember 26, 2022 | msn.comThis Diet Reduces Heart Risks for Those With HypertensionSeptember 7, 2022 | reuters.comHypertension Diagnostics IncJuly 13, 2022 | msn.comCan Diabetes And High Blood Pressure Lead to Kidney Failure?January 25, 2022 | nasdaq.comHypertension Diagnostics, Inc. (HDII)See More Headlines Receive HDII Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Hypertension Diagnostics and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/25/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolOTCMKTS:HDII CUSIP44914V104 CIK1058828 Webwww.hypertensiondiagnostics.com Phone(407) 449-6151Fax651-687-0485Employees2,017Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable Beta-2.35 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleGrowth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.Get This Free Report Key ExecutivesLiangjian PengChief Executive OfficerKey CompetitorsAdynxxOTCMKTS:ADYXCalmare TherapeuticsOTCMKTS:CTTCCVR MedicalOTCMKTS:CRRVFDex LiquidatingOTCMKTS:DXTRQEndologixOTCMKTS:ELGXQView All Competitors HDII Stock Analysis - Frequently Asked Questions How have HDII shares performed in 2024? Hypertension Diagnostics' stock was trading at $0.0010 on January 1st, 2024. Since then, HDII stock has decreased by 80.0% and is now trading at $0.0002. View the best growth stocks for 2024 here. What other stocks do shareholders of Hypertension Diagnostics own? Based on aggregate information from My MarketBeat watchlists, some companies that other Hypertension Diagnostics investors own include Victory Square Technologies (VSQTF), Eyenovia (EYEN), ProShares UltraShort Energy (DUG), Cypress Semiconductor (CY), Celldex Therapeutics (CLDX), Century Aluminum (CENX), Black Diamond Therapeutics (BDTX), BioCryst Pharmaceuticals (BCRX) and How do I buy shares of Hypertension Diagnostics? Shares of HDII stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:HDII) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsJim Cramer’s “The Biggest Drug Ever”Behind the MarketsThe only accurate crypto trading system I know …Weiss RatingsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hypertension Diagnostics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.